Remove 2019 Remove Documentation Remove Hospitals
article thumbnail

Pharmacist to Clinical Strategy Leader: Brendan Doran on Building a Career in Biotech

The Nontraditional Pharmacist

So, we would have spoken in 2019. And then how do you develop documents to basically get approval from the FDA to study your drug in humans? And those are sites, sometimes those are hospitals, sometimes they’re physician’s offices, there’s for-profit, clinical research sites out there. So, good talking to you.

FDA
article thumbnail

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

PharmTech

It builds on drug calculations topics previously described (1), including guidance documents (2–5). FDA guidance documents illustrate labeling salt drugs and associated active moieties. Discussion topics Part two of this series ( click here for part one ) addresses numeric calculations for types of bulk drugs. About the authors Paul L.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hospital pharmacist-led re-evaluation of medication errors: a pilot study

Hospital Pharmacy Europe

Karl-Johan Lindner and Marie Halvarsson, from the pharmacy at Västerås Hospital in Sweden, describe a new approach to improve the categorisation of medication errors that uses the skills of hospital pharmacists to reclassify reported incidents based on a given medication process. One million injections or infusions and 1.7

article thumbnail

Rimegepant rejected by NICE for treatment of acute migraine

Hospital Pharmacy Europe

However, in its consultation document, while accepting that the drug is likely to reduce pain at 2 hours post-dose more than placebo, NICE added that the evidence submitted by the manufacturer, for patients who have not responded to two triptans, is uncertain and hence requires more evidence. .’

article thumbnail

Teva faces EU antitrust probe over MS drug Copaxone

pharmaphorum

The Commission will also examine whether Teva may have launched a communication campaign to create a “false perception” about the health risks of prescribing generic competitors, aimed at healthcare professionals and hospitals.

article thumbnail

Increasing patient engagement with UK clinical trials

pharmaphorum

An international key opinion former, Richard is the founding co-editor of the Journal of Research Involvement and Engagement, chairs BBMRI-ERIC’s Stakeholder Forum, and chaired the NCRI Consumer Forum 2012-2019. In 2014 Keith was fortunate to become a full-time salaried patient research ambassador at Liverpool Heart and Chest Hospital Trust.

article thumbnail

The 20 Key Moments in the 340B Program's 30-Year History

Omnicell

Interestingly, the 340B law was actually included in a veterans healthcare bill (the Veterans Health Care Act) that also established a separate drug pricing program for veterans hospitals. It also raised the DSH payment cap for some rural and small urban hospitals to 12%. 340B providers expressed significant concern.